Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuno Vale

Showing results (91-100 of 230) with videos related to

Pageof 23
Sort By:
Biomolecules|February 29, 2020
Current and Novel Therapies Against Helminthic Infections: The Potential of Antioxidants Combined with DrugsNuno Vale, Maria João Gouveia, Fátima Gärtner
Cells|September 8, 2023
Systemic Inflammatory Disorders, Immunosuppressive Treatment and Increase Risk of Head and Neck Cancers-A Narrative Review of Potential Physiopathological and Biological MechanismsNuno Vale, Mariana Pereira, Rui Amaral Mendes
Life (Basel, Switzerland)|July 29, 2025
Repurposed Antipsychotics as Potential Anticancer Agents: Clozapine Efficacy and Dopaminergic Pathways in Neuroblastoma and GlioblastomaCatarina Moura, Maria João Gouveia, Nuno Vale
Cancers|April 14, 2025
Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted TherapiesEduarda Carvalho, Sule Canberk, Fernando Schmitt, et al.
Frontiers in Pharmacology|May 19, 2018
Microglia P2Y<sub>13</sub> Receptors Prevent Astrocyte Proliferation Mediated by P2Y<sub>1</sub> ReceptorsClara Quintas, Nuno Vale, Jorge Gonçalves, et al.
Biomolecules|February 25, 2022
Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer CellsDiana Duarte, Alexandra Rêma, Irina Amorim, et al.
Genes|March 28, 2026
MicroRNA-Gene Networks Distinguish Hormone Receptor Status in HER2-Low Breast Cancer: An Integrative Transcriptomic AnalysisEduarda Carvalho, Andreia Brandão, Fernando Schmitt, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 7, 2020
Understanding Breast cancer: from conventional therapies to repurposed drugsBárbara Costa, Irina Amorim, Fátima Gärtner, et al.
Cancers|September 23, 2022
Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous CarcinomaMariana Nunes, Diana Duarte, Nuno Vale, et al.
Biomolecules|October 27, 2022
Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of ActionDiana Duarte, Mariana Nunes, Sara Ricardo, et al.
Pageof 23

Showing results (91-100 of 230) with videos related to

Sort By:
Pageof 23
Biomolecules|February 29, 2020
Current and Novel Therapies Against Helminthic Infections: The Potential of Antioxidants Combined with DrugsNuno Vale, Maria João Gouveia, Fátima Gärtner
Cells|September 8, 2023
Systemic Inflammatory Disorders, Immunosuppressive Treatment and Increase Risk of Head and Neck Cancers-A Narrative Review of Potential Physiopathological and Biological MechanismsNuno Vale, Mariana Pereira, Rui Amaral Mendes
Life (Basel, Switzerland)|July 29, 2025
Repurposed Antipsychotics as Potential Anticancer Agents: Clozapine Efficacy and Dopaminergic Pathways in Neuroblastoma and GlioblastomaCatarina Moura, Maria João Gouveia, Nuno Vale
Cancers|April 14, 2025
Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted TherapiesEduarda Carvalho, Sule Canberk, Fernando Schmitt, et al.
Frontiers in Pharmacology|May 19, 2018
Microglia P2Y<sub>13</sub> Receptors Prevent Astrocyte Proliferation Mediated by P2Y<sub>1</sub> ReceptorsClara Quintas, Nuno Vale, Jorge Gonçalves, et al.
Biomolecules|February 25, 2022
Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer CellsDiana Duarte, Alexandra Rêma, Irina Amorim, et al.
Genes|March 28, 2026
MicroRNA-Gene Networks Distinguish Hormone Receptor Status in HER2-Low Breast Cancer: An Integrative Transcriptomic AnalysisEduarda Carvalho, Andreia Brandão, Fernando Schmitt, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 7, 2020
Understanding Breast cancer: from conventional therapies to repurposed drugsBárbara Costa, Irina Amorim, Fátima Gärtner, et al.
Cancers|September 23, 2022
Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous CarcinomaMariana Nunes, Diana Duarte, Nuno Vale, et al.
Biomolecules|October 27, 2022
Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of ActionDiana Duarte, Mariana Nunes, Sara Ricardo, et al.
Pageof 23